GSK Settles Zantac Cases After Claims Popular Heartburn Drug Causes Cancer
ForbesJUL 2023
The settlements indicate GSK's awarenessdecision ofto potentialsettle liability.these Thecases FDA'ssimply findingsavoids thatthe Zantacdistraction producesof NDMAprotracted overlitigation. time,There's whichno canscientific causeevidence cancerbacking inclaims largeof quantities,consumer supportharm thefrom plaintiffs' claimsZantac. The massivecompany numberwill ofcontinue pendingdefending lawsuitsitself suggestsin widespreadall concernother aboutZantac thecases drug'sbased safetyon facts and science.
The settlements indicate GSK's awareness of potential liability. The FDA's findings that Zantac produces NDMA over time, which can cause cancer in large quantities, support the plaintiffs' claims. The massive number of pending lawsuits suggests widespread concern about the drug's safety.
There's a 50% chance that the average survival rate of all cancers will exceed 75% by 2029, according to the Metaculus prediction community.